| Autor: |
Agnese Comelli, Camilla Genovese, Andrea Lombardi, Chiara Bobbio, Luigia Scudeller, Umberto Restelli, Antonio Muscatello, Spinello Antinori, Paolo Bonfanti, Salvatore Casari, Antonella Castagna, Francesco Castelli, Antonella d’Arminio Monforte, Fabio Franzetti, Paolo Grossi, Matteo Lupi, Paola Morelli, Stefania Piconi, Massimo Puoti, Luigi Pusterla, Angelo Regazzetti, Marco Rizzi, Stefano Rusconi, Valentina Zuccaro, Andrea Gori, Alessandra Bandera, the ASP Lomb Study Group |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-7 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2047-2994 |
| DOI: |
10.1186/s13756-022-01152-5 |
| Popis: |
Abstract Discontinuation of antimicrobial stewardship programs (ASPs) and increased antibiotic use were described during SARS-CoV-2 pandemic. In order to measure COVID-19 impact on ASPs in a setting of high multidrug resistance organisms (MDRO) prevalence, a qualitative survey was designed. In July 2021, eighteen ID Units were asked to answer a questionnaire about their hospital characteristics, ASPs implementation status before the pandemic and impact of SARS-CoV-2 pandemic on ASPs after the 1st and 2nd pandemic waves in Italy. Nine ID centres (50%) reported a reduction of ASPs and in 7 cases (38.9%) these were suspended. After the early pandemic waves, the proportion of centres that restarted their ASPs was higher among the ID centres where antimicrobial stewardship was formally identified as a priority objective (9/11, 82%, vs 2/7, 28%). SARS-CoV-2 pandemic had a severe impact in ASPs in a region highly affected by COVID-19 and antimicrobial resistance but weaknesses related to the pre-existent ASPs might have played a role. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
